ZA90299B - Substituted quinolinecarboxylic acids - Google Patents

Substituted quinolinecarboxylic acids

Info

Publication number
ZA90299B
ZA90299B ZA90299A ZA90299A ZA90299B ZA 90299 B ZA90299 B ZA 90299B ZA 90299 A ZA90299 A ZA 90299A ZA 90299 A ZA90299 A ZA 90299A ZA 90299 B ZA90299 B ZA 90299B
Authority
ZA
South Africa
Prior art keywords
quinolinecarboxylic acids
substituted
substituted quinolinecarboxylic
disclosed
arthritis
Prior art date
Application number
ZA90299A
Other languages
English (en)
Inventor
John Frank Poletto
Frank Poletto John
Dennis William Powell
William Powell Dennis
Diane Harris Boschelli
Harris Boschelli Diane
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA90299B publication Critical patent/ZA90299B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
ZA90299A 1989-01-17 1990-01-16 Substituted quinolinecarboxylic acids ZA90299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/298,585 US4968702A (en) 1989-01-17 1989-01-17 Substituted quinolinecarboxylic acids

Publications (1)

Publication Number Publication Date
ZA90299B true ZA90299B (en) 1990-10-31

Family

ID=23151154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90299A ZA90299B (en) 1989-01-17 1990-01-16 Substituted quinolinecarboxylic acids

Country Status (17)

Country Link
US (1) US4968702A (ko)
EP (1) EP0379145B1 (ko)
JP (1) JP3004025B2 (ko)
KR (1) KR0140076B1 (ko)
AT (1) ATE152711T1 (ko)
AU (1) AU624471B2 (ko)
CA (1) CA2007740C (ko)
DE (1) DE69030632T2 (ko)
DK (1) DK0379145T3 (ko)
ES (1) ES2100851T3 (ko)
GR (1) GR3023585T3 (ko)
HK (1) HK1008019A1 (ko)
IE (1) IE900169L (ko)
IL (1) IL92898A (ko)
NZ (1) NZ232111A (ko)
PH (1) PH26961A (ko)
ZA (1) ZA90299B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999038846A1 (en) * 1998-01-30 1999-08-05 Procept, Inc. Immunosuppressive agents
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
MXPA05001642A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados de naftaleno como inhibidores de metaloproteinasas de matriz.
US7138412B2 (en) * 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2898615A1 (en) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287804C (ko) *
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
FR2166297A1 (en) * 1972-01-07 1973-08-17 Rosenberg Eli 2-(4-isopropylphenyl)quinoline-4-carboxylic acid - as a non-toxic, analgesic agent
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (en) * 1983-07-22 1990-12-05 E.I. Du Pont De Nemours And Company Phenylquinolinecarboxylic acids and derivatives as antitumor agents
EP0318093A3 (en) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments

Also Published As

Publication number Publication date
IL92898A0 (en) 1990-09-17
PH26961A (en) 1992-12-28
CA2007740A1 (en) 1990-07-17
KR900011733A (ko) 1990-08-02
JP3004025B2 (ja) 2000-01-31
DE69030632D1 (de) 1997-06-12
GR3023585T3 (en) 1997-08-29
HK1008019A1 (en) 1999-04-30
DE69030632T2 (de) 1997-10-02
AU4850290A (en) 1990-07-26
US4968702A (en) 1990-11-06
DK0379145T3 (da) 1997-05-26
KR0140076B1 (ko) 1998-06-01
AU624471B2 (en) 1992-06-11
ATE152711T1 (de) 1997-05-15
EP0379145A3 (en) 1991-07-17
EP0379145B1 (en) 1997-05-07
CA2007740C (en) 1999-12-07
JPH02229166A (ja) 1990-09-11
ES2100851T3 (es) 1997-07-01
IE900169L (en) 1990-07-17
IL92898A (en) 1994-11-28
NZ232111A (en) 1992-07-28
EP0379145A2 (en) 1990-07-25

Similar Documents

Publication Publication Date Title
GR3023585T3 (en) Substituted quinolinecarboxylic acids
HU913865D0 (en) Process for the production of n-(4-/5/cyclopentyl-carbonyl)-amino-1-methyl-indole-3-yl-methyl(-3-metoxi-/benzoyl/)-2-methyl-benzosulphonamide
ZA90479B (en) Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
HU9302330D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
HUT58335A (en) Process for the production of n-(pyrrolo/2,3-d/pyrimidine-3-yl-acyl)-glutamine-acid derivatives
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
HUT69063A (en) Process for the preparation of 1,4-disubstituted-5(4h)-tetrazolinones
ITMI920794A0 (it) Procedimento per la produzione di carbone attivo
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
GB2177091B (en) 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease
CS675086A2 (en) Zpusob vyroby novych derivatu 1a 13 bromergolinu
ITMI922551A0 (it) Procedimento per la produzione di carbone attivo
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
HUT55994A (en) Process for producing pharmaceutical compositions for producing or inhibiting contraction of the pupil
HU9200117D0 (en) Process for the production of 3'-fluor-pirimidine nucleozides
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2708484B1 (fr) Procédé d'amélioration du broyage des minéraux.
FR2623801B1 (fr) Procede de purification de l'hexamethylenediamine
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins
ZA905699B (en) Novel process for the synthesis of 2-fluoro-1-olefins
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis